Article
Subcellular compartmentalization of docking protein-1 contributes to progression in colorectal cancer.
EBioMedicine - 1 Jun 2016
Friedrich Teresa, Söhn Michaela, Gutting Tobias, Janssen Klaus-Peter, Behrens Hans-Michael, Röcken Christoph, Ebert Matthias P A, Burgermeister Elke
Abstract excerpt
Full-length (FL) docking protein-1 (DOK1) is an adapter protein which inhibits growth factor and immune response pathways in normal tissues, but is frequently lost in human cancers. Small DOK1 variants remain in cells of solid tumors and leukemias, albeit, their functions are elusive. To assess the so far unknown role of DOK1 in colorectal cancer (CRC), we generated DOK1 mutants which mimic the domain structure...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
